6505--Hydralazine RFP

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAC PHARMACEUTICALS (36E797)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36E79725R0060

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents2
The National Acquisition Center (NAC) Pharmaceuticals, a federal office, has issued a solicitation (Procurement Identifier: 36E79725R0060) for the supply of Hydralazine, as indicated by the notice titled "6505--Hydralazine RFP." This procurement opportunity is classified under NAICS Code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and carries the Product Service Code 6505, denoting drugs and biologicals. The primary objective of this solicitation is to secure a reliable source of Hydralazine, a pharmaceutical product, for use within federal healthcare operations. The scope of the contract will encompass the manufacturing and delivery of Hydralazine in accordance with applicable federal standards and requirements. Contractors are expected to demonstrate their capability to consistently produce and supply Hydralazine that meets all regulatory and quality specifications throughout the contract lifecycle. Key requirements for this opportunity include compliance with the latest NAICS classification (2022 version) and adherence to all relevant pharmaceutical manufacturing standards. The intended outcome is to ensure an uninterrupted supply of Hydralazine to support federal healthcare needs, with a focus on quality, reliability, and regulatory compliance. The contracting entity for this procurement is NAC Pharmaceuticals (Organization Key: 500000036), operating as a federal office. Interested parties should direct all inquiries and correspondence to the primary contact, Amber Zavala, at [email protected]. This solicitation is currently active, with a posting date of May 11, 2025, and a response deadline of November 13, 2025. The opportunity is listed on SAM.gov (Opportunity ID: 409f56de7eeb483b86c708b34b48fb5e), where additional attachments related to the solicitation are available for review. Contractors considering this opportunity should evaluate their capacity to meet the pharmaceutical manufacturing requirements for Hydralazine, maintain compliance with federal standards, and deliver consistent quality over the duration of the contract. No specific set-aside requirements or special considerations are noted in the provided information. This procurement represents a stable and ongoing need for Hydralazine within the federal healthcare system, making it suitable for qualified manufacturers with established capabilities in pharmaceutical production.